Cargando…

Immune‐related signature predicts the prognosis and immunotherapy benefit in bladder cancer

BACKGROUND: There is no good prognostic model that could predict the prognosis of bladder cancer (BCa) and the benefit of immunotherapy. METHODS: Through the least absolute shrinkage and selection operator (LASSO) algorithm, we constructed a 13‐mRNA immune signature from the TCGA cohort (n = 406). W...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yejinpeng, Chen, Liang, Yu, Mengxue, Fang, Yayun, Qian, Kaiyu, Wang, Gang, Ju, Lingao, Xiao, Yu, Wang, Xinghuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571842/ https://www.ncbi.nlm.nih.gov/pubmed/32841548 http://dx.doi.org/10.1002/cam4.3400

Ejemplares similares

Novel Biomarkers Associated With Progression and Prognosis of Bladder Cancer Identified by Co-expression Analysis
por: Wang, Yejinpeng, et al.
Publicado: (2019)

Epigenetic signature predicts overall survival clear cell renal cell carcinoma
por: Wang, Yejinpeng, et al.
Publicado: (2020)

Development and Validation of a Six-Gene Prognostic Signature for Bladder Cancer
por: Xu, Fei, et al.
Publicado: (2021)

The inhibitory effect of silencing CDCA3 on migration and proliferation in bladder urothelial carcinoma
por: Shen, Dexin, et al.
Publicado: (2021)

DNA polymerase POLD1 promotes proliferation and metastasis of bladder cancer by stabilizing MYC
por: Wang, Yejinpeng, et al.
Publicado: (2023)

Melatonin inhibits bladder tumorigenesis by suppressing PPARγ/ENO1-mediated glycolysis
por: Shen, Dexin, et al.
Publicado: (2023)

E3 ubiquitin ligase RNF126 affects bladder cancer progression through regulation of PTEN stability
por: Xu, Huimin, et al.
Publicado: (2021)

The immune‐related biomarker TEK inhibits the development of clear cell renal cell carcinoma (ccRCC) by regulating AKT phosphorylation
por: Chen, Siming, et al.
Publicado: (2021)

Pectolinarigenin inhibits bladder urothelial carcinoma cell proliferation by regulating DNA damage/autophagy pathways
por: Deng, Zhao, et al.
Publicado: (2023)

PPARγ inhibition regulates the cell cycle, proliferation and motility of bladder cancer cells
por: Cheng, Songtao, et al.
Publicado: (2019)

The role and function of PPARγ in bladder cancer
por: Peng, Tianchen, et al.
Publicado: (2020)

Inhibition of MELK produces potential anti‐tumour effects in bladder cancer by inducing G1/S cell cycle arrest via the ATM/CHK2/p53 pathway
por: Chen, Song, et al.
Publicado: (2019)

Identification of a prognostic gene signature based on an immunogenomic landscape analysis of bladder cancer
por: Luo, Yongwen, et al.
Publicado: (2020)

Comprehensive genomic profiling of urothelial carcinoma cell lines reveals hidden research bias and caveats
por: Luo, Yongwen, et al.
Publicado: (2020)

Histone methyltransferase SETD2: An epigenetic driver in clear cell renal cell carcinoma
por: Yu, Mengxue, et al.
Publicado: (2023)

TRPM8 Inhibition Regulates the Proliferation, Migration and ROS Metabolism of Bladder Cancer Cells
por: Wang, Gang, et al.
Publicado: (2020)

Genomewide identification of a novel six‐LncRNA signature to improve prognosis prediction in resectable hepatocellular carcinoma
por: Wu, Ying, et al.
Publicado: (2018)

The inhibitory effect of melatonin on human prostate cancer
por: Shen, Dexin, et al.
Publicado: (2021)

Conditional reprogramming: Modeling urological cancer and translation to clinics
por: Liu, Wei, et al.
Publicado: (2020)

Reply to Peng He, Xiaohui Wang, and Hao Li’s Letter to the Editor re: Yu Xiao, Kaiyu Qian, Yongwen Luo, et al. Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Renal Failure Patients: A Potential Covert Source of Infection. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.03.025
por: Xiao, Yu, et al.
Publicado: (2020)

Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Renal Failure Patients: A Potential Covert Source of Infection
por: Xiao, Yu, et al.
Publicado: (2020)

Construction of immune‐related risk signature for renal papillary cell carcinoma
por: Wang, Zhongyu, et al.
Publicado: (2018)

Downregulated hsa_circ_0077837 and hsa_circ_0004826, facilitate bladder cancer progression and predict poor prognosis for bladder cancer patients
por: Shen, Chong, et al.
Publicado: (2020)

Identification of 9 key genes and small molecule drugs in clear cell renal cell carcinoma
por: Luo, Yongwen, et al.
Publicado: (2019)

PRR11 promotes ccRCC tumorigenesis by regulating E2F1 stability
por: Chen, Siming, et al.
Publicado: (2021)

BORA regulates cell proliferation and migration in bladder cancer
por: Cheng, Songtao, et al.
Publicado: (2020)

Identification and validation of a novel signature for prediction the prognosis and immunotherapy benefit in bladder cancer
por: Zhang, Yichi, et al.
Publicado: (2022)

EFEMP2 suppresses epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway in human bladder cancer
por: Zhou, Qiang, et al.
Publicado: (2019)

Tumor purity as a prognosis and immunotherapy relevant feature in gastric cancer
por: Gong, Zhe, et al.
Publicado: (2020)

Establishing the prediction models for recurrence and progression of T1G3 bladder urothelial carcinoma
por: Chen, Song, et al.
Publicado: (2019)

EFEMP2 suppresses epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway in human bladder cancer: Erratum
por: Zhou, Qiang, et al.
Publicado: (2022)

Correlation between immune signature and high‐density lipoprotein cholesterol level in stage II/III colorectal cancer
por: Wang, Yun, et al.
Publicado: (2019)

The cholesterol esterification inhibitor avasimibe suppresses tumour proliferation and metastasis via the E2F-1 signalling pathway in prostate cancer
por: Xiong, Kangping, et al.
Publicado: (2021)

Simvastatin induces cell cycle arrest and inhibits proliferation of bladder cancer cells via PPARγ signalling pathway
por: Wang, Gang, et al.
Publicado: (2016)

DNA Methylation-Based Panel Predicts Survival of Patients With Clear Cell Renal Cell Carcinoma and Its Correlations With Genomic Metrics and Tumor Immune Cell Infiltration
por: Liu, Xiao-Ping, et al.
Publicado: (2020)

Checkpoint blockade‐based immunotherapy in the context of tumor microenvironment: Opportunities and challenges
por: Duan, Jingjing, et al.
Publicado: (2018)

An outcome model for human bladder cancer: A comprehensive study based on weighted gene co‐expression network analysis
por: Xiong, Yaoyi, et al.
Publicado: (2019)

Gene signature based on B cell predicts clinical outcome of radiotherapy and immunotherapy for patients with lung adenocarcinoma
por: Han, Linzhi, et al.
Publicado: (2020)

Targeting immunotherapy for bladder cancer using anti‐CD3× B7‐H3 bispecific antibody
por: Ma, Wanru, et al.
Publicado: (2018)

Development of an IFNγ response‐related signature for predicting the survival of cutaneous melanoma
por: Hu, Baohui, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_28n829h8g3tk2orfo5pe33r8fb